Literature DB >> 33388092

Immunological analysis and differential genes screening of venous thromboembolism.

Li-Na Gao1, Qiang Li2, Jian-Qin Xie3, Wan-Xia Yang1, Chong-Ge You4.   

Abstract

PURPOSE: To explore the pathogenesis of venous thromboembolism (VTE) and provide bioinformatics basis for the prevention and treatment of VTE.
METHODS: The R software was used to obtain the gene expression profile data of GSE19151, combining with the CIBERSORT database, obtain immune cells and differentially expressed genes (DEGs) of blood samples of VTE patients and normal control, and analyze DEGs for GO analysis and KEGG pathway enrichment analysis. Then, the protein-protein interaction (PPI) network was constructed by using the STRING database, the key genes (hub genes) and immune differential genes were screened by Cytoscape software, and the transcription factors (TFs) regulating hub genes and immune differential genes were analyzed by the NetworkAnalyst database.
RESULTS: Compared with the normal group, monocytes and resting mast cells were significantly expressed in the VTE group, while regulatory T cells were significantly lower. Ribosomes were closely related to the occurrence of VTE. 10 hub genes and immune differential genes were highly expressed in VTE. MYC, SOX2, XRN2, E2F1, SPI1, CREM and CREB1 can regulate the expressions of hub genes and immune differential genes.
CONCLUSIONS: Ribosomal protein family genes are most relevant to the occurrence and development of VTE, and the immune differential genes may be the key molecules of VTE, which provides new ideas for further explore the pathogenesis of VTE.

Entities:  

Keywords:  Bioinformatics analysis; Differentially expressed genes; Immune cell; Immune differential gene; Ribosome; Venous thromboembolism

Year:  2021        PMID: 33388092     DOI: 10.1186/s41065-020-00166-6

Source DB:  PubMed          Journal:  Hereditas        ISSN: 0018-0661            Impact factor:   3.271


  36 in total

Review 1.  International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  Dominique Farge; Henri Bounameaux; Benjamin Brenner; Francis Cajfinger; Philippe Debourdeau; Alok A Khorana; Ingrid Pabinger; Susan Solymoss; James Douketis; Ajay Kakkar
Journal:  Lancet Oncol       Date:  2016-10       Impact factor: 41.316

2.  Risk of Arterial Thromboembolism in Patients With Cancer.

Authors:  Babak B Navi; Anne S Reiner; Hooman Kamel; Costantino Iadecola; Peter M Okin; Mitchell S V Elkind; Katherine S Panageas; Lisa M DeAngelis
Journal:  J Am Coll Cardiol       Date:  2017-08-22       Impact factor: 24.094

3.  Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism.

Authors:  Frank Rühle; Anika Witten; Andrei Barysenka; Andreas Huge; Astrid Arning; Christine Heller; Anne Krümpel; Rolf Mesters; Andre Franke; Wolfgang Lieb; Mona Riemenschneider; Milan Hiersche; Verena Limperger; Ulrike Nowak-Göttl; Monika Stoll
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113

4.  How I treat cancer-associated venous thromboembolism.

Authors:  Noémie Kraaijpoel; Marc Carrier
Journal:  Blood       Date:  2018-11-26       Impact factor: 22.113

Review 5.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

6.  Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016.

Authors:  Duo Huang; Pak-Hei Chan; Hoi-Lam She; Chun Ka Wong; Chi-Wai Ho; Yang-Yang Cheng; Esther W Chan; Chern-En Chiang; Chung-Wah Siu
Journal:  Thromb Res       Date:  2018-04-21       Impact factor: 3.944

Review 7.  Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: A new challenge for personalized therapy.

Authors:  Giuditta Benincasa; Dario Costa; Teresa Infante; Roberta Lucchese; Francesco Donatelli; Claudio Napoli
Journal:  Thromb Res       Date:  2019-03-15       Impact factor: 3.944

Review 8.  Venous thromboembolism and cancer: pathophysiology and incidence.

Authors:  Hans Stricker
Journal:  Vasa       Date:  2014-07       Impact factor: 1.961

9.  Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.

Authors:  Sara Lindström; Lu Wang; Erin N Smith; William Gordon; Astrid van Hylckama Vlieg; Mariza de Andrade; Jennifer A Brody; Jack W Pattee; Jeffrey Haessler; Ben M Brumpton; Daniel I Chasman; Pierre Suchon; Ming-Huei Chen; Constance Turman; Marine Germain; Kerri L Wiggins; James MacDonald; Sigrid K Braekkan; Sebastian M Armasu; Nathan Pankratz; Rebecca D Jackson; Jonas B Nielsen; Franco Giulianini; Marja K Puurunen; Manal Ibrahim; Susan R Heckbert; Scott M Damrauer; Pradeep Natarajan; Derek Klarin; Paul S de Vries; Maria Sabater-Lleal; Jennifer E Huffman; Theo K Bammler; Kelly A Frazer; Bryan M McCauley; Kent Taylor; James S Pankow; Alexander P Reiner; Maiken E Gabrielsen; Jean-François Deleuze; Chris J O'Donnell; Jihye Kim; Barbara McKnight; Peter Kraft; John-Bjarne Hansen; Frits R Rosendaal; John A Heit; Bruce M Psaty; Weihong Tang; Charles Kooperberg; Kristian Hveem; Paul M Ridker; Pierre-Emmanuel Morange; Andrew D Johnson; Christopher Kabrhel; David-Alexandre Trégouët; Nicholas L Smith
Journal:  Blood       Date:  2019-11-07       Impact factor: 25.476

10.  Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease.

Authors:  Scott M Damrauer; Pradeep Natarajan; Derek Klarin; Emma Busenkell; Renae Judy; Julie Lynch; Michael Levin; Jeffery Haessler; Krishna Aragam; Mark Chaffin; Mary Haas; Sara Lindström; Themistocles L Assimes; Jie Huang; Kyung Min Lee; Qing Shao; Jennifer E Huffman; Christopher Kabrhel; Yunfeng Huang; Yan V Sun; Marijana Vujkovic; Danish Saleheen; Donald R Miller; Peter Reaven; Scott DuVall; William E Boden; Saiju Pyarajan; Alex P Reiner; David-Alexandre Trégouët; Peter Henke; Charles Kooperberg; J Michael Gaziano; John Concato; Daniel J Rader; Kelly Cho; Kyong-Mi Chang; Peter W F Wilson; Nicholas L Smith; Christopher J O'Donnell; Philip S Tsao; Sekar Kathiresan; Andrea Obi
Journal:  Nat Genet       Date:  2019-11-01       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.